Eileen Sawyer

Eileen Sawyer

Company: uniQure

Job title: Vice President, Global Medical Affairs

Bio:

Eileen Sawyer joined uniQure in 2016, where she serves as Vice President and Head of Medical Affairs, leading uniQure’s medical affairs activities across the portfolio with a focus on supporting the hemophilia B gene therapy program. Prior to joining uniQure, she spent 3 years at Alexion Pharmaceuticals where she served as the scientific communications lead for the launch of asfotase alfa (Strensiq), an enzyme replacement for a rare metabolic disease. Eileen earned her PhD in Neuroscience from Emory University in 2011 and conducted her post-doctoral training in preclinical drug discovery at Harvard University prior to transitioning to industry.

Seminars:

Panel Discussion – Assessing the Commercial Realities of Launching Gene Therapies in the Blood Disorder Space 9:15 am

Determining the most effective ways of demonstrating product value Ensuring accessibility of products through co-operation with payers and patients Discussing creative solutions to increase accessibility to patients by overcoming cost and geographic barriersRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.